Currently under review by the U.S. Food and Drug Administration (FDA), the new Biograph mCT has an anticipated mid-2012 international market launch.
1 Products are still under development and not commercially available yet. Future availability cannot be ensured.
2 Source: World Alzheimer's Report: Alzheimer's Disease International.
Ad Statistics
Times Displayed: 112822
Times Visited: 6727 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
3 Based on competitive literature available at time of publication. Data on file.
4,5 SMART Neuro AC and syngo.PET Neuro are pending 510(k) clearance and are not yet commercially available in the U.S.
The here mentioned product/features are not commercially available. Due to regulatory reasons, future availability in any country cannot be guaranteed. Please contact your local Siemens organization for further details.
The outcomes achieved by the Siemens customers described herein were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist - e.g., hospital size, case mix, level of IT adoption - there can be no guarantee that others will achieve the same results.
Launched by Siemens Healthcare Sector in November 2011, Agenda 2013 is a two-year global initiative to further strengthen the Healthcare Sector's innovative power and competitiveness. Specific measures will be implemented in four fields of action: Innovation, Competitiveness, Regional Footprint, and People Development.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source - from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros. For further information please visit: www.siemens.com/healthcare.
Contact: Jeff Bell
610-448-1477
jeffrey.t.bell@siemens.com
Back to HCB News
